Efficacy and safety of liposomal irinotecan combined with targeted second-line therapy for metastatic colorectal cancer

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2024
This article has no abstract
Epistemonikos ID: b8be97da46ce29b15a8cfe712961925271c214e1
First added on: Apr 08, 2025